Bloomberg Law
March 24, 2023, 5:35 PM

AbbVie, Merz’s $54.4 Million Settlement in Namenda Suit Approved

Katie Arcieri
Katie Arcieri
Senior Reporter

AbbVie Inc. and Merz Holding Gmbh & Co. affiliates received final approval for a $54.4 million settlement of a lawsuit that claimed the pharmaceutical companies conspired to block generic competition for the Alzheimer’s drug Namenda.

The settlement, approved by Judge Colleen McMahon in the US District Court for the Southern District of New York on Thursday, comes after nearly eight years of litigation.

McMahon gave preliminary approval for the settlement in November 2022.

Sergeants Benevolent Association Health and Welfare Fund (SBA) in 2015 filed class action claims against Forest Laboratories, an AbbVie unit, and a Merz subsidiary, as well as ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.